BioDlink makes first international shipment of bevacizumab to Colombia

FDA expands Merck's Winrevair indication for pulmonary arterial hypertension based on Phase 3 trial results

Boehringer Ingelheim's JASCAYD (nerandomilast) IPF treatment gains Chinese regulatory approval

ACM Biolabs reports ACM-CpG Phase 1 study findings in tumour treatment

Arcturus reports interim Phase 2 data for ARCT-032 in cystic fibrosis

PureTech highlights Phase 2b data supporting deupirfenidone's safety and efficacy in older IPF patients

GSK reports positive Phase III data for low-carbon version of Ventolin inhaler

Merck reports long-term survival benefits of Keytruda in non-small cell lung cancer

Sanofi reports data showing high-dose flu vaccine delivers superior protection for older adults

AstraZeneca wins US FDA approval for Tezspire in chronic rhinosinusitis with nasal polyps

Sichuan Kelun-Biotech presents positive Phase 3 trial results for sac-TMT

SOPHiA DDM Digital Twins launched to simulate patient outcomes and support oncology decisions

Akeso's HARMONi-6 ivonescimab Phase III study accepted by The Lancet and selected for ESMO 2025 presentation

Novocure announces presentation of new TTFields research at EANO and ESMO 2025 meetings

Mabwell to present latest 7MW3711 clinical results at 2025 ESMO Congress